Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Hemorrhage Phase 4 ClinicalTrials
Blood Coagulation Disorders; Hemorrhage; Hemostatic Disorders; Intracranial Hemorrhages Phase 4 ClinicalTrials
Osteoarthritis; Osteoarthritis, Knee Phase 2 ClinicalTrials
Hemorrhage; Shock, Hemorrhagic Phase 2/Phase 3 ClinicalTrials
Shock; Shock, Septic Phase 2 ClinicalTrials
Hemorrhage; Intracranial Hemorrhages Phase 1 ClinicalTrials
Supranuclear Palsy, Progressive Phase 1 ClinicalTrials
Blood Coagulation Disorders; Hemostatic Disorders Phase 3 ClinicalTrials
Fasciitis; Fasciitis, Plantar Phase 4 ClinicalTrials
Blood Coagulation Disorders; Hemorrhage; Hemostatic Disorders Phase 3 ClinicalTrials
Blood Coagulation Disorders; Hemostatic Disorders Phase 4 ClinicalTrials
Liver Diseases Phase 4 ClinicalTrials
Aneurysm; Aortic Aneurysm, Abdominal; Blood Coagulation Disorders; Hemostatic Disorders Phase 4 ClinicalTrials
Aneurysm; Aortic Aneurysm; Aortic Aneurysm, Thoracic Phase 4 ClinicalTrials
Hemorrhage Phase 2 ClinicalTrials
CONTENTS